Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

(E/Z)-4-hydroxy Tamoxifen is a mixture of (E)-4-hydroxy tamoxifen and (Z)-4-hydroxy tamoxifen.1 (Z)-4-hydroxy Tamoxifen is an active metabolite of the estrogen receptor antagonist tamoxifen (Item Nos. 13258 | 11629) and is formed from tamoxifen by the cytochrome P450 (CYP) isoform CYP2D6. (Z)-4-hydroxy Tamoxifen (100 nM) inhibits 17β-estradiol-induced increases in the mRNA encoding progesterone receptor in MCF-7 breast cancer cells.2 (Z)-4-hydroxy Tamoxifen inhibits the proliferation of MCF-7 and MDA-MB-231 breast cancer cells (IC50s = 27 and 18 µM, respectively).3
WARNING This product is not for human or veterinary use.
1. Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: Prominent roles for CYP3A and CYP2D6. J. Pharmacol. Exp. Ther. 310(3), 1062-1075 (2004).
2. Endoxifen (4-
3. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen. Horm. Metab. Res. 36(5), 277-280 (2004).
Multiomic profiling reveals that prostaglandin E2 reverses aged muscle stem cell dysfunction, leading to increased regeneration and strength. Cell Stem Cell 32, 1154-1169 (2025).